Market Place
Sourcing Support
XBiotech Study Suggests Breakthrough For Advanced Pancreatic Cancer
18 Jun 2024 //
GLOBENEWSWIRE
Kindos` Generic Leucovorin Calcium Receives Approval in the U.S.
19 Jul 2023 //
FDA
Hainan`s Generic Leucovorin Calcium Receives Approval in the U.S.
10 Jul 2023 //
FDA
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde
03 Aug 2022 //
BUSINESSWIRE
Health product recall Leucovorin Calcium Injection: Out of Specification
13 May 2022 //
HEALTH CANADA
Zanidatamab PII Trial Shows Promising Data in First-Line HER2-Positive GEA
16 Sep 2021 //
BUSINESSWIRE
Enforcement Report - Week of August 25, 2021
25 Aug 2021 //
FDA
Enforcement Report - Week of August 19, 2020
19 Aug 2020 //
FDA
Riconpharma`s Generic Leucovorin Calcium Receives Approval in US
31 Jul 2020 //
FDA
Enforcement Report - Week of October 23, 2019
24 Oct 2019 //
FDA
Ingenus Pharms` Generic Leucovorin Calcium Receives Approval in US
27 Nov 2018 //
FDA
Sanofi-Aventis-Withdrawal of Approval of 20 New Drug Applications
19 Oct 2018 //
FEDERAL REGISTER
Fresenius Kabi USA`s Generic Leucovorin Calcium Receives Approval In US
28 Jul 2018 //
FDA
Shire wins EU licence for pancreatic cancer drug Onivyde
18 Oct 2016 //
PM LIVE
PharmaEngine Announces Korean Ministry of Food and Drug Safety Accepted ONIVYDE
10 May 2016 //
PR NEWSWIRE
Express Scripts Champions $1 per Pill Access to an Alternative for Daraprim
01 Dec 2015 //
PR NEWS WIRE
Lilly`s CYRAMZA® (Ramucirumab) Receives Supplemental Approval in USA for Cancer
25 Apr 2015 //
LILLY
IDT Australia release on FDA nod for 23 generics begs the question: Where`s the beef?
14 Apr 2015 //
FIERCE PHARMA ASIA
FDA Drug Shortages: Leucovorin Calcium Lyophilized Powder for Injection
25 Mar 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.